1. Spinraza 12 mg raztopina za injiciranje

Spinraza 12 mg raztopina za injiciranje

Nusinersen

General information

Drug nameSpinraza 12 mg raztopina za injiciranje
Medicine nameNusinersen
National drug code3005919
PMS ID—
SNOMED descriptive name code—
Legal statusZdravilo z dovoljenjem za promet
Drug groupChemical Medicinal Product
OriginatorYes
Orphan drugNo

Marketing authorization

Procedure typePotrditev podatkov za CP zdravila (modro okence)
No. and date of decision/certificate1024-38/2017-2, 29. 6. 2017
Authorization validity dateUntil further notice
Marketing end date—
Application type—
Authorization/certificate holderBiogen Netherlands B.V.

Drug safety monitoring

Additional safety monitoringNo
Precautionary measure/dispensing restrictions—
Pregnancy prevention programmeNo
Controlled access programme(s)No

ATC codes

MMUSCULO-SKELETAL SYSTEM
M09OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09AOther drugs for disorders of the musculo-skeletal system
M09AXOther drugs for disorders of the musculo-skeletal system
M09AX07nusinersen

Route of administration

Route of administration name
Intratekalna uporaba

Settlement data for compulsory health insurance billing

Substitute medicine

Preparation—
Valid from – to—

Clinical use data

Methods of use—
Indications—
Rounding factor—
DivisibleNo
Division for easier swallowingNo
Division for dosage adjustmentNo
Paediatric populationNo

Shortage actions

Substitute medicine in case of shortage - industrial medicine—
Substitute medicine in case of shortage - magistral or galenic medicine—
Prescribing restriction in case of drug shortageNo
Dispensing restriction in case of shortage or emergencyNo
Dispensing restriction for foreign prescriptions in case of shortage or emergencyNo
Export restrictionNo

Drug status

The medicinal product is present in wholesale distribution.

Last drug update date:9. 7. 2026
TEST APPLICATION